Customer Publication

Interfacing Antibody-based Microarrays and Digital Holography Enables Label-free Detection for Loss of Cell Volume

Authors: Z. El-Schich et al.

Journal: Future science oa (2015)

Institution: Malmö University

Research Areas: Cancer research, drug development

Cell Lines: Jurkat, U2932 (Jurkat: human T-cell acute lymphoblastic leukemia; U2932: human diffuse large B-cell lymphoma)

Summary: The article provides proof of concept for using holographic microscopy combined with antibody-based microarray technology for detecting morphological changes in captured cells.

Keywords: HoloMonitor M2, cell counter, cell morphology, antibody, cellular, holography, microarray, volume

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2